FMP

FMP

Enter

MYMD - MyMD Pharmaceuticals...

Financial Statements of MyMD Pharmaceuticals, Inc.(MYMD), MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developi

photo-url-https://financialmodelingprep.com/image-stock/MYMD.png

MyMD Pharmaceuticals, Inc.

MYMD

NASDAQ

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

1.8 USD

0.025 (1.39%)

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep